Concepedia

Samuel S. Engel

SS

101

Publications

6.8K

Citations

43

H-Index

1946

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

George Washington University

Clinical Research Institute

University of Oxford

Oxford Centre for Diabetes, Endocrinology and Metabolism

Samuel S. Engel is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, diabetes, and public health.

ORCID

Top concepts

Publications per year

1946–2024

101

Publications

101

Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects

Frans J.Th. Wackers, Lawrence H. Young, Silvio E. Inzucchi et al. · Diabetes Care · 2004 · 786 citations · Full text

Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus

Kristy Iglay, Hakima Hannachi, Patrick Joseph Howie et al. · Current Medical Research and Opinion · 2016 · 488 citations

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

Tina Vilsbøll, Julio Rosenstock, H Yki-Järvinen et al. · Diabetes Obesity and Metabolism · 2009 · 303 citations · Full text

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

Debora Williams‐Herman, Samuel S. Engel, Elizabeth Round et al. · BMC Endocrine Disorders · 2010 · 254 citations · Full text

Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort

Zhuo Chen, Miao Feng, Andrew D. Paterson et al. · Proceedings of the National Academy of Sciences · 2016 · 238 citations · Full text

Rows per page

1–5 of 101